Streetbeat News

Products Services

GROM

Grom Social Enterprises Inc. (NASDAQ:GROM), a media, technology, and entertainment company, announced that its subsidiary, Top Draw Animation (TDA), has secured over $2.9M in new animation production assignments, including the largest single order in its 25-year history. These projects, supported by tax incentives from the Philippines, underscore TDA's role as a leading provider of premium animation services globally. Acquired by Grom in 2016, TDA offers high-capacity Harmony and Flash production pipelines and benefits from up to a 25% cash rebate for approved work in the Philippines.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:46 pm

OSIS

OSI Systems, Inc. (OSIS) announced a $6 million order from an advanced engineered solutions OEM for its Optoelectronics and Manufacturing division to provide electronic assemblies. CEO Deepak Chopra expressed commitment to supporting the OEM and anticipation for continued collaboration.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:45 pm

ICCM

An independent study in Japan showed 0% breast cancer local recurrence 5 years after treatment with IceCure's ProSense, demonstrating its potential as a standard treatment for early-stage breast cancer. The study, published in Breast Cancer journal, highlighted excellent cosmetic outcomes, high patient satisfaction, and improved quality of life post-cryoablation. IceCure's distribution partner in Japan, Terumo Corporation, plans to submit a regulatory clearance application for ProSense in H2 2024. IceCure expects to receive a total of $13.2 million from Terumo for exclusive distribution rights in Japan.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:45 pm

BIOX

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announced the approval of three new bio-insecticidal/bio-nematicidal solutions by Brazil's Ministry of Agriculture and Livestock. These solutions, derived from inactivated cells of the company's proprietary Burkholderia platform, mark a significant regulatory milestone in Brazil, the world's leading bio-control market. This approval enables the commercialization of these products in Brazil, potentially opening the door for future product launches. Bioceres' bio-control solutions are commercialized under the Rizobacter brand and other third-party brands in Brazil. The company's CEO, Federico Trucco, highlighted the approval as a key milestone for growth in Brazil and noted the global relevance of this market to the company.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:43 pm

CWD

Caliber (NASDAQ:CWD), a real estate investor, developer, and manager, announced the sale of a 50-acre parcel in Johnstown, Colorado, to the Archdiocese of Denver for $7.7 million. The land, part of a larger 190-acre purchase in June 2021, is intended for a new Catholic high school. This sale is part of Caliber's Johnstown Development, a 750-acre master-planned project. The development is expected to include multifamily, retail, and industrial spaces, aiming to boost the Northern Colorado area's growth and investment.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:41 pm

BLDP

Ballard Power Systems anticipates its 2024 revenue to be heavily weighted towards the second half of the year, mirroring its 2023 pattern, with about 30% expected in the first half and 70% in the latter half. The company has not provided specific revenue or net income guidance for 2024 due to the nascent stage of the hydrogen fuel cell market. Ballard's projected total operating expenses for 2024 are between $145 million and $165 million, with capital expenditures estimated to be between $50 million and $70 million.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:40 pm

NBIX

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced its participation in the European Congress of Endocrinology 2024, where it will present data from its CAHtalyst Program on crinecerfont for CAH and studies on modified-release hydrocortisone for primary adrenal insufficiency and CAH. The presentations will include baseline characteristics from Phase 3 studies, Phase 2 CHAMPAIN study results, and a Phase 3 extension study on the efficacy, safety, and tolerability of modified-release hydrocortisones.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:38 pm

DTIL

Precision BioSciences, Inc. (NASDAQ:DTIL) announced its partner iECURE received FDA Fast Track designation for ECUR-506, a gene insertion program for treating neonatal onset Ornithine Transcarbamylase (OTC) deficiency. This designation, which aims to expedite the development and review of treatments for serious conditions, highlights the potential of Precision's ARCUS platform. ECUR-506, utilizing a PCSK9-specific ARCUS nuclease licensed from Precision, has also received Rare Pediatric Disease and Orphan Drug designations from the FDA, and Orphan designation from the European Commission. The OTC-HOPE study, a Phase 1/2 trial, is currently enrolling in the UK, with sites in the US and Australia activating later this year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:37 pm

STI

Solidion Technology, Inc. (NASDAQ:STI) introduced its BEEP technology for solid-state batteries, aiming to revolutionize the electric vehicle (EV) industry by solving major design and manufacturing challenges. The BEEP platform enables the production of high-voltage, high-capacity battery packs with reduced weight, volume, and cost by simplifying the battery's structure. This technology is expected to facilitate the commercialization of solid-state batteries, offering advantages such as safety, fast charging, and extended range. Solidion's parent company, Global Graphene Group, has been recognized for its leading position in solid-state battery IP.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:33 pm

SIDU

Sidus Space announced its role as a teammate on the NASA Lunar Terrain Vehicle Services contract, marking a significant milestone for the company in its involvement with space exploration and services.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:31 pm